HPV Vaccine in Women with HIV
Part of Immune system & allergy, Infections clinical trials.
This study looks at how well the HPV vaccine works in women living with HIV and whether it helps make cervical cancer screening more accurate. If you are a woman with HIV between 21 and 40 years old and already part of certain other HIV studies, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman living with HIV, between 21 and 40 years old.
- You are already enrolled in a specific HIV study (like PHACS, SMARTT, AMP Up, or HOPE).
- You are willing to give consent and let the researchers access your medical records and other study data.
- You are not currently pregnant (per your report) and do not have active cervical precancer requiring colposcopy.
- You do not have a bleeding disorder or have had a hysterectomy (removal of the cervix).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well the Gardasil 9 HPV vaccine works in people assigned male at birth, including those with HIV and those taking hormone therapy. Results could help protect against HPV-related cancers.
This study tests a self-collection kit for HPV, a virus that can cause cervical cancer. It aims to make screening easier for women with HIV who haven't had a Pap test recently, and to find earlier signs of risk.
This trial tests whether giving a lower dose of the HPV vaccine can still be effective and safe for women living with HIV. It may be helpful if you need HPV protection and the study’s dose schedule could reduce vaccine burden.
This study offers a way to screen for cervical cancer using an HPV self-test. It is designed for women who may not have had a recent Pap smear and are from certain minority groups.
This study looks at whether getting the HPV vaccine along with regular cervical cancer screening (using an HPV test) can help prevent cervical cancer in women living with HIV. It is designed to be done as part of your usual HIV clinic visits, making it easier for you to take part.
This trial tests an HPV vaccine in people living with HIV to see if it is safe and helps their immune system fight HPV. HPV can cause certain cancers, and this study hopes to protect people with HIV who are more at risk.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.